Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Zoetis Stock Fell 11.7% in March

By Maxx Chatsko – Apr 9, 2020 at 8:37AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The animal health company outperformed the S&P 500 last month. As of early April, it has also gained back most of its losses.

What happened

Shares of Zoetis (ZTS 0.56%) fell 11.7% last month, according to data provided by S&P Global Market Intelligence. That was actually better than the 12.5% tumble of the S&P 500. What's more, the animal health stock has clawed back most of the ground lost in March through the first week of April.

The company hasn't told investors how the coronavirus pandemic has affected operations, if at all. Since major social-distancing orders were issued, Zoetis has only scheduled its first-quarter 2020 earnings conference call and announced a minor acquisition. Can the growth stock really avoid all of the economic uncertainty? 

A declining chart on a chalkboard.

Image source: Getty Images.

So what

Zoetis develops health products for companion animals (cats, dogs, and horses) and livestock (cattle, pigs, chickens, fish, and the like). Demand for those products probably hasn't declined very much. Food production is an essential business in every part of the world, although it's reasonable to expect some purchases to be delayed. Similarly, the family dog's flea medication might not be a priority right now.

The geographic distribution of operations figures to be favorable for investors, too. Over half the company's revenue was generated in the United States in 2019. By comparison, only 8% of total revenue was derived from combined sales in Italy, Spain, Germany, France, and the United Kingdom. 

Now what

While it's reasonable to expect the abrupt economic slowdown to negatively affect the animal health leader, the business hasn't provided an update to investors. That will surely come when Zoetis announces first-quarter 2020 operating results on May 6, if the information isn't provided sometime in April.

Maxx Chatsko has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Zoetis Inc. Stock Quote
Zoetis Inc.
ZTS
$149.44 (0.56%) $0.84

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.